These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 1279315)

  • 21. Electrophysiologic properties of sotalol and d-sotalol. A current view.
    Touboul P
    Eur Heart J; 1993 Nov; 14 Suppl H():24-9. PubMed ID: 7904935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The class III antiarrhythmic effect of sotalol exerts a reverse use-dependent positive inotropic effect in the intact canine heart.
    Peralta AO; John RM; Gaasch WH; Taggart PI; Martin DT; Venditti FJ
    J Am Coll Cardiol; 2000 Oct; 36(4):1404-10. PubMed ID: 11028502
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concentration/response relations for the multiple antiarrhythmic actions of sotalol.
    Woosley RL; Barbey JT; Wang T; Funck-Brentano C
    Am J Cardiol; 1990 Jan; 65(2):22A-27A; discussion 35A-36A. PubMed ID: 2294688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The advantage of d-sotalol over dl-sotalol in a patient with ventricular arrhythmias and comorbid bronchospasm.
    Kuntz RE; Ruskin JN; Weinberger S; Lorell BH
    Chest; 1992 Nov; 102(5):1627-9. PubMed ID: 1424914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Are the antiarrhythmic-defibrillating effects of D-sotalol due to or despite the prolongation of the action potential duration?
    Manoach M; Varon D; Tribulova N; Shainberg A; Zinman T; Isaack A; Imanaga I
    Life Sci; 1999 Oct; 65(23):PL273-9. PubMed ID: 10622238
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Electrophysiologic effects of d-sotalol in humans.
    McComb JM; McGovern B; McGowan JB; Ruskin JN; Garan H
    J Am Coll Cardiol; 1987 Jul; 10(1):211-7. PubMed ID: 3597990
    [TBL] [Abstract][Full Text] [Related]  

  • 27. d-Sotalol: a new potent class III anti-arrhythmic agent.
    Taggart P; Sutton P; Donaldson R
    Clin Sci (Lond); 1985 Nov; 69(5):631-6. PubMed ID: 4053517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is class III antiarrhythmic activity important?
    Singh BN
    Cardiovasc Drugs Ther; 1990 Jun; 4 Suppl 3():597-602. PubMed ID: 2275889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hemodynamic effects of the D- and L-isomers of sotalol on normal myocardium.
    Hoffmeister HM; Beyer M; Seipel L
    Cardiovasc Drugs Ther; 1991 Dec; 5(6):1027-33. PubMed ID: 1801889
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences in the Effects of d- and dl-Sotalol on Isolated Human Ventricular Muscle: Electromechanical Activity After Beta-Adrenoceptor Stimulation.
    Lathrop DA; Varró A; Nánási PP; Bódi I; Takyi E; Pankucsi C
    J Cardiovasc Pharmacol Ther; 1996 Jan; 1(1):65-74. PubMed ID: 10684401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Letter: Duration of action of beta-adrenergic blocking drugs.
    Besterman E; McCarthy C
    Br Med J; 1974 Jul; 3(5925):257. PubMed ID: 4602142
    [No Abstract]   [Full Text] [Related]  

  • 32. A fungal metabolite that eliminates motion artifacts.
    Jalife J; Morley GE; Tallini NY; Vaidya D
    J Cardiovasc Electrophysiol; 1998 Dec; 9(12):1358-62. PubMed ID: 9869535
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison of electrophysiological and antiarrhythmic effects of vernakalant, ranolazine, and sotalol in canine pulmonary vein sleeve preparations.
    Sicouri S; Pourrier M; Gibson JK; Lynch JJ; Antzelevitch C
    Heart Rhythm; 2012 Mar; 9(3):422-9. PubMed ID: 22019863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term antiarrhythmic efficacy and safety of d-sotalol in patients with ventricular tachycardia and a low ejection fraction.
    Koch KT; Düren DR; van Zwieten PA
    Cardiovasc Drugs Ther; 1995 Jun; 9(3):437-43. PubMed ID: 8527354
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacodynamic, pharmacokinetic and antiarrhythmic properties of d-sotalol, the dextro-isomer of sotalol.
    Advani SV; Singh BN
    Drugs; 1995 May; 49(5):664-79. PubMed ID: 7601009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sotalol. An updated review of its pharmacological properties and therapeutic use in cardiac arrhythmias.
    Fitton A; Sorkin EM
    Drugs; 1993 Oct; 46(4):678-719. PubMed ID: 7506652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Electrophysiologic and antiarrhythmic effects of D-sotalol.
    Brachmann J; Beyer T; Schmitt C; Schöls W; Montero M; Hilbel T; Schweizer M; Kübler W
    J Cardiovasc Pharmacol; 1992; 20 Suppl 2():S91-5. PubMed ID: 1279315
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sotalol.
    Hohnloser SH; Woosley RL
    N Engl J Med; 1994 Jul; 331(1):31-8. PubMed ID: 8202100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiarrhythmic actions of DL-sotalol in ventricular and supraventricular arrhythmias.
    Singh BN
    J Cardiovasc Pharmacol; 1992; 20 Suppl 2():S75-90. PubMed ID: 1279313
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.